KE (NYSE:BEKE – Free Report) had its price objective boosted by Barclays from $30.00 to $33.00 in a research note released on Monday,Benzinga reports. Barclays currently has an overweight rating on the stock.
Several other equities research analysts also recently issued reports on BEKE. Citigroup started coverage on KE in a research note on Tuesday, September 10th. They issued a “buy” rating and a $23.80 price objective for the company. Bank of America raised KE from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $24.00 to $28.00 in a research note on Wednesday, October 30th.
View Our Latest Research Report on BEKE
KE Stock Up 1.5 %
Institutional Investors Weigh In On KE
Hedge funds and other institutional investors have recently made changes to their positions in the company. Central Asset Investments & Management Holdings HK Ltd purchased a new stake in shares of KE during the 3rd quarter worth about $1,124,000. Swedbank AB purchased a new stake in shares of KE during the 1st quarter worth about $3,393,000. Lighthouse Investment Partners LLC purchased a new stake in shares of KE during the 2nd quarter worth about $1,142,000. SG Americas Securities LLC raised its stake in shares of KE by 37.6% during the 2nd quarter. SG Americas Securities LLC now owns 235,853 shares of the company’s stock worth $3,337,000 after purchasing an additional 64,449 shares in the last quarter. Finally, MBB Public Markets I LLC purchased a new stake in shares of KE during the 2nd quarter worth about $627,000. 39.34% of the stock is owned by hedge funds and other institutional investors.
About KE
KE Holdings Inc, through its subsidiaries, engages in operating an integrated online and offline platform for housing transactions and services in the People's Republic of China. It operates through four segments: Existing Home Transaction Services, New Home Transaction Services, Home Renovation and Furnishing, and Emerging and Other Services.
Recommended Stories
- Five stocks we like better than KE
- What is a Special Dividend?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Find and Profitably Trade Stocks at 52-Week Lows
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Makes a Stock a Good Dividend Stock?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for KE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KE and related companies with MarketBeat.com's FREE daily email newsletter.